Acth and Ill-defined disorder - a phase IV clinical study of FDA data

Summary:

Ill-defined disorder is reported as a side effect among people who take Acth (corticotropin), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Benlysta, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Ill-defined disorder when taking Acth. It is created by eHealthMe based on reports of 5,384 people who have side effects when taking Acth from the FDA, and is updated regularly.

What is Acth?

Acth has active ingredients of corticotropin. eHealthMe is studying from 5,402 Acth users. Check the latest studies of Acth.

What is Ill-defined disorder?

Ill-defined disorder is found to be associated with 1,460 drugs and 1,260 conditions by eHealthMe. Check the latest studies of Ill-defined disorder.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

5,384 people reported to have side effects when taking Acth.
Among them, 11 people (0.2%) have Ill-defined disorder.

Among these 11 people:

How long have people been on Acth when they have Ill-defined disorder? *

What is the gender of people who have Ill-defined disorder when taking Acth? *

female: 90.91 %
male: 9.09 %

What is the age of people who have Ill-defined disorder when taking Acth? *

What are other drugs people take besides Acth? *

What are other side effects people have besides Ill-defined disorder? *

Abasia (inability to walk): 3 people, 27.27%
High Blood Pressure: 3 people, 27.27%
Jc Virus Infection: 3 people, 27.27%
Viral Infection: 3 people, 27.27%
Lupus Encephalitis (a chronic inflammatory autoimmune disorder that may affect brain): 3 people, 27.27%
Movement - Uncontrolled Or Slow: 3 people, 27.27%
Drooling (drop saliva uncontrollably from the mouth): 3 people, 27.27%
Arrhythmias (irregular heartbeat): 3 people, 27.27%
Progressive Multifocal Leukoencephalopathy (rapidly progressive neuromuscular disease caused by opportunistic infection of brain cells): 3 people, 27.27%
Sensation Of Foreign Body: 3 people, 27.27%

What are the existing conditions these people have? *

Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 3 people, 27.27%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 27.27%
Rheumatoid Factor: 1 person, 9.09%
Nephrotic Syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema): 1 person, 9.09%
Myopathy (a muscular disease in which the muscle fibres do not function): 1 person, 9.09%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 9.09%
Dermatomyositis (inflammation of the skin and underlying muscle tissue, typically occurring as an autoimmune condition or associated with internal cancer): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Acth and have Ill-defined disorder?

- Check whether Ill-defined disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Acth:

Acth (5,402 reports)

Browse all side effects of Acth:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ill-defined disorder:

Ill-defined disorder (1,460 drugs)

Browse all the conditions that are associated with Ill-defined disorder:

Ill-defined disorder (1,260 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on corticotropin (the active ingredients of Acth) and Acth (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.